HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
Canada
3167382
Filed on 2022-08-09
3167382
Filed on 2022-08-09
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
Australia
2021220957
Filed on 2022-08-04
2021220957
Filed on 2022-08-04
PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY
South Korea
10-2022-7023239
Filed on 2020-12-11
10-2022-7023239
Filed on 2020-12-11
PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY
European Patent
20899103.4
Filed on 2020-12-11
20899103.4
Filed on 2020-12-11
PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY
Australia
2020403013
Filed on 2020-12-11
2020403013
Filed on 2020-12-11
Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use
Italy
16751434.8
Filed on 2018-02-01
16751434.8
Filed on 2018-02-01
Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use
Ireland
16751434.8
Filed on 2018-02-01
16751434.8
Filed on 2018-02-01
Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use
United Kingdom
16751434.8
Filed on 2018-02-01
16751434.8
Filed on 2018-02-01
Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use
France
16751434.8
Filed on 2018-02-01
16751434.8
Filed on 2018-02-01